Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Lipocine to Present at the B. Riley NASH Symposium
 Thursday, October 24, 2019
 12:00pm - 12:25pm PDT